Replies to post #91001 on Avid Bioservices Inc (CDMO)

[freethemice]

I think you are referring to the Avastin trial that was the basis for first-line approval and combined Avastin
with carboplatin and paclitaxel, so any comparison of the survival curves wouldn't really mean anything.